New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.

Alice VarnavaRobert BracchiKaren SamuelsDyfrig A Hughes Philip Alexander Routledge

Published in: PharmacoEconomics (2019)

This review highlights the work carried out by AWMSG over a 5-year period, and provides evidence to support the effectiveness of the appraisal process in terms of patients in Wales gaining earlier access to medicines and efficiency through reduced duplication with NICE.

Keyphrases

end stage renal disease
chronic kidney disease
randomized controlled trial
peritoneal dialysis
prognostic factors
type diabetes
patient reported outcomes
patient reported